Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 11 : Hundreds of jobs coming to our area. The billion-dollar investment from a company that makes a popular weight-loss drug
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Allakos Inc
(NQ:
ALLK
)
1.120
-0.050 (-4.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
234,019
Open
1.170
Bid (Size)
1.100 (40)
Ask (Size)
1.150 (4)
Prev. Close
1.170
Today's Range
1.100 - 1.170
52wk Range
0.9799 - 5.640
Shares Outstanding
86,560,315
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
May 28, 2024
From
Allakos Inc.
Via
GlobeNewswire
ALLK Stock Earnings: Allakos Meets EPS for Q1 2024
May 09, 2024
ALLK stock results show that Allakos met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-59.12%
-59.12%
1 Month
-21.68%
-21.68%
3 Month
-10.40%
-10.40%
6 Month
-61.77%
-61.77%
1 Year
-76.12%
-76.12%
More News
Read More
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
May 09, 2024
From
Allakos Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 03, 2024
Via
InvestorPlace
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
Where Allakos Stands With Analysts
December 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
Via
InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
April 09, 2024
Via
InvestorPlace
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
February 26, 2024
From
Allakos Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From
Allakos Inc.
Via
GlobeNewswire
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Allakos (ALLK) Stock Down 57% Today?
January 16, 2024
Via
InvestorPlace
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
January 16, 2024
Via
Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
December 18, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.